Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers
Brief Summary: The study of safety of a new organic arsenic compound in the treatment of hematological malignancies.